ISTH 2025: VELORA Pioneer - Preliminary safety and PK/PD data of a first-in-human study of HMB-002 in Type 1 Von Willebrand disease
Presented at the ISTH (International Society on Thrombosis and Haemostasis) 2025 Congress
To view the presentation, click here